Organ Involvement, GVHD Severity Predict Ruxolitinib Failure in Chronic GVHD
In updated results from a real-world analysis presented at the 2021 ASH Annual Meeting, researchers confirmed that ruxolitinib is an effective treatment...
A Study Looks at Unplanned Health Care Resource Utilization Among CAR T-Cell Therapy Recipients
While chimeric antigen receptor (CAR) T-cell therapy is a potentially life-saving option for patients with hematologic cancers, it may lead to higher...
In a Real-World Analysis, CLL Treatment Has Shifted from Chemoimmunotherapy to Targeted Therapies
An analysis of real-world data regarding the treatment of patients with chronic lymphocytic leukemia (CLL) revealed that standards of care are shifting...
Venetoclax-Based Time-Limited Combination Treatments Versus Standard Therapy in Frontline CLL
A study presented at the 2021 American Society of Hematology Annual Meeting aimed to assess the efficacy and safety of three regimens...